{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:31:06Z","timestamp":1789471866152,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology","doi-asserted-by":"crossref","award":["BT\/PR6806\/GBD\/27\/480\/2012"],"award-info":[{"award-number":["BT\/PR6806\/GBD\/27\/480\/2012"]}],"id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006143","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["SB\/YS\/LS-61\/2014"],"award-info":[{"award-number":["SB\/YS\/LS-61\/2014"]}],"id":[{"id":"10.13039\/501100006143","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neuint.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T06:27:58Z","timestamp":1476512878000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease"],"prefix":"10.1016","volume":"101","author":[{"given":"Nivedita","family":"Bhattacharjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6283-5367","authenticated-orcid":false,"given":"Anupom","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2016.10.001_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in\u00a0vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuint.2016.10.001_bib2","first-page":"527","article-title":"Sulfate and cysteine levels in the plasma of patients with Parkinson's disease","volume":"16","author":"Allain","year":"1995","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2016.10.001_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","article-title":"Brain peroxidase and catalase in Parkinson disease","volume":"32","author":"Ambani","year":"1975","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2016.10.001_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","article-title":"Hyperhomocysteinemia and neurologic disorders: a review","volume":"10","author":"Ansari","year":"2014","journal-title":"J.\u00a0Clin. Neurol."},{"key":"10.1016\/j.neuint.2016.10.001_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"2016a","key":"10.1016\/j.neuint.2016.10.001_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neulet.2016.06.011","article-title":"L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra","volume":"628","author":"Bhattacharjee","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2016.10.001_bib7","first-page":"47","article-title":"Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson's disease","volume":"6","author":"Bhattacharjee","year":"2016","journal-title":"Biochem. Biophy. Rep."},{"key":"10.1016\/j.neuint.2016.10.001_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson's disease: animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuint.2016.10.001_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson's disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuint.2016.10.001_bib10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-007-9213-6","article-title":"Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats","volume":"27","author":"Borah","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2016.10.001_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5214\/ans.0972.7531.2009.160406","article-title":"Long term L-DOPA treatment causes production of 6-OHDA in the mouse striatum: involvement of hydroxyl radical","volume":"16","author":"Borah","year":"2009","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.neuint.2016.10.001_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mehy.2012.05.008","article-title":"L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients","volume":"79","author":"Borah","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuint.2016.10.001_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12264-013-1330-2","article-title":"Contribution of \u03b2-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease","volume":"29","author":"Borah","year":"2013","journal-title":"Neurosci. Bullet"},{"key":"10.1016\/j.neuint.2016.10.001_bib14","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/0006-2952(83)90014-X","article-title":"Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide","volume":"32","author":"Brigelius","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2016.10.001_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2005.12.073","article-title":"Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats","volume":"1075","author":"Chandra","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2016.10.001_bib16","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","article-title":"Redox imbalance in Parkinson's disease","volume":"1780","author":"Chinta","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2016.10.001_bib17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuint.2016.10.001_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2016.10.001_bib19","doi-asserted-by":"crossref","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuint.2016.10.001_bib20","first-page":"107","article-title":"Homocysteine and Parkinson's Disease: a complex relationship","volume":"1","author":"Doherty","year":"2013","journal-title":"J.\u00a0Neurol. Disord."},{"key":"10.1016\/j.neuint.2016.10.001_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","article-title":"Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease","volume":"80","author":"Duan","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.10.001_bib23","first-page":"292","article-title":"Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease","volume":"60","author":"Hattori","year":"1993","journal-title":"Adv. Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2016.10.001_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410300409","article-title":"Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease","volume":"30","author":"Hattori","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2016.10.001_bib25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.mehy.2011.09.009","article-title":"Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress","volume":"77","author":"Hoffman","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuint.2016.10.001_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ane.12106","article-title":"Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis","volume":"128","author":"Hu","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuint.2016.10.001_bib27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2016.10.001_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2013.01.032","article-title":"Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats","volume":"236","author":"Karuppagounder","year":"2013","journal-title":"Neuroscience"},{"issue":"19","key":"10.1016\/j.neuint.2016.10.001_bib29","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","article-title":"Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled","volume":"26","author":"Keeney","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.10.001_bib30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1212\/01.wnl.0000266639.50620.d1","article-title":"A\u00a0new look at james Parkinson's essay on the shaking palsy","volume":"69","author":"Kempster","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neuint.2016.10.001_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0197-4580(02)00133-1","article-title":"Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion","volume":"24","author":"Khaldy","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2016.10.001_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000007984","article-title":"Elevated plasma levels of homocysteine in Parkinson's disease","volume":"40","author":"Kuhn","year":"1998","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuint.2016.10.001_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-1331.2004.00973.x","article-title":"Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration","volume":"12","author":"Lamberti","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuint.2016.10.001_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuro.2005.01.008","article-title":"Effects of homocysteine on the dopaminergic system and behavior in rodents","volume":"26","author":"Lee","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2016.10.001_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2016.10.001_bib36","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1001\/archneur.64.11.1646","article-title":"Mild parkinsonian signs and plasma homocysteine concentration in community-dwelling elderly individuals","volume":"64","author":"Louis","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2016.10.001_bib37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/syn.21658","article-title":"Sodium salicylate protects against rotenone-induced parkinsonism in rats","volume":"67","author":"Madathil","year":"2013","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2016.10.001_bib38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0955-2863(99)00033-9","article-title":"A\u00a0new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection","volume":"10","author":"Melnyk","year":"1999","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.neuint.2016.10.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2016.10.001_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-211-73574-9_14","article-title":"Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects","volume":"72","author":"Nagatsu","year":"2007","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.neuint.2016.10.001_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1196\/annals.1427.002","article-title":"Oxidative stress and energy crises in neuronal dysfunction","volume":"1147","author":"Nicholls","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2016.10.001_bib42","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1002\/mds.21675","article-title":"The pathogenesis of cell death in Parkinson's disease","volume":"22","author":"Olanow","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2016.10.001_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04996.x","article-title":"Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease","volume":"104","author":"Pandey","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.10.001_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","article-title":"Complex I deficiency in Parkinson's disease frontal cortex","volume":"1189","author":"Parker","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2016.10.001_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lfs.2015.07.031","article-title":"The potential physiological crosstalk and interrelationship between two sovereign endogenous amines, melatonin and homocysteine","volume":"139","author":"Paul","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2016.10.001_bib46","first-page":"1989","article-title":"L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: elephant in the room","volume":"1860","author":"Paul","year":"2016","journal-title":"BBA"},{"key":"10.1016\/j.neuint.2016.10.001_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuint.2015.07.025","article-title":"Cholesterol - a putative endogenous contributor towards Parkinson's disease","volume":"90","author":"Paul","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2016.10.001_bib48","series-title":"The Rat Brain in Stereotaxic Coordinates","first-page":"1","author":"Paxinos","year":"1988"},{"key":"10.1016\/j.neuint.2016.10.001_bib49","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuint.2016.10.001_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00726-003-0026-8","article-title":"Homocysteine and oxidative stress","volume":"25","author":"Perna","year":"2003","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuint.2016.10.001_bib51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","article-title":"Parkinson's disease: a disorder due to nigral glutathione deficiency?","volume":"33","author":"Perry","year":"1982","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2016.10.001_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2016.10.001_bib53","first-page":"288","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"60","author":"Schapira","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuint.2016.10.001_bib54","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J.\u00a0Neurosci."},{"issue":"6","key":"10.1016\/j.neuint.2016.10.001_bib55","doi-asserted-by":"crossref","first-page":"A259","DOI":"10.1289\/ehp.119-a259a","article-title":"Rotenone and paraquat linked to Parkinson's disease: human exposure study supports years of animal studies","volume":"119","author":"Spivey","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuint.2016.10.001_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1196\/annals.1427.015","article-title":"The role of mitochondria in reactive oxygen species metabolism and signaling","volume":"1147","author":"Starkov","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2016.10.001_bib57","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuint.2016.10.001_bib58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1600-079X.2003.00096.x","article-title":"Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum","volume":"36","author":"Thomas","year":"2004","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1016\/j.neuint.2016.10.001_bib59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(99)02202-7","article-title":"In\u00a0vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"852","author":"Thomas","year":"2000","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuint.2016.10.001_bib60","doi-asserted-by":"crossref","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","article-title":"A\u00a0guide to neurotoxic animal models of Parkinson's disease","volume":"1","author":"Tieu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuint.2016.10.001_bib61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2016.10.001_bib62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nchembio.85","article-title":"Reconciling the chemistry and biology of reactive oxygen species","volume":"4","author":"Winterbourn","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuint.2016.10.001_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1007-4376(08)60003-9","article-title":"Effect and mechanism of homocysteine on Parkinson's disease induced by 6-OHDA","volume":"22","author":"Xing","year":"2008","journal-title":"J.\u00a0Nanjing Med. Univ."},{"key":"10.1016\/j.neuint.2016.10.001_bib64","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2174\/092986710792232012","article-title":"Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?","volume":"17","author":"Zoccolella","year":"2010","journal-title":"Curr. Med. Chem."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616302078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616302078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:24:17Z","timestamp":1718825057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018616302078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":63,"alternative-id":["S0197018616302078"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2016.10.001","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}